The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

41 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of KDM5A inhibitors: Homology modeling, virtual screening and structure-activity relationship analysis.EBI
Sichuan University
Recent Progress in Histone Demethylase Inhibitors.EBI
University of Oxford
Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective Inactivators.EBI
Kyoto Prefectural University of Medicine
Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors.EBI
University of Oxford
Identification of Jumonji AT-Rich Interactive Domain 1A Inhibitors and Their Effect on Cancer Cells.EBI
Kyoto Prefectural University of Medicine
Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3.EBI
University of North Carolina At Chapel Hill
Identification of the KDM2/7 histone lysine demethylase subfamily inhibitor and its antiproliferative activity.EBI
Kyoto Prefectural University of Medicine
Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors.EBI
Genentech
Identification of potent, selective KDM5 inhibitors.EBI
Constellation Pharmaceuticals
Lead optimization of a pyrazolo[1,5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies.EBI
Genentech
Identification of novel lysine demethylase 5-selective inhibitors by inhibitor-based fragment merging strategy.EBI
Kyoto Prefectural University of Medicine
Identification of ortho-hydroxy anilide as a novel scaffold for lysine demethylase 5 inhibitors.EBI
Kyoto Prefectural University of Medicine
Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor.EBI
University of Oxford
The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.EBI
University of North Carolina
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.EBI
The University of Texas M.D. Anderson Cancer Center
Structure-based design and discovery of potent and selective KDM5 inhibitors.EBI
Celgene
Methyllysine binding domains: Structural insight and small molecule probe development.EBI
University of Connecticut
Investigations on small molecule inhibitors targeting the histone H3K4 tri-methyllysine binding PHD-finger of JmjC histone demethylases.EBI
University of Oxford
From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.EBI
Genentech
Insights into the Action of Inhibitor Enantiomers against Histone Lysine Demethylase 5A.EBI
The University of Texas M.D. Anderson Cancer Center
Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine demethylase 4D (KDM4D) inhibitors.EBI
Sichuan University
The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family.BDB
Cnrs
 
Calorimetric Studies on the Complexation of Several Ferrocene Derivatives by .alpha.- and .beta.-Cyclodextrin. Effects of Urea on the Thermodynamic ParametersBDB
University of Miami
Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARdelta agonists.BDB
Johnson & Johnson Pharmaceutical
Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.BDB
Gsk
Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.BDB
Toronto General Research Institute
Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones.BDB
Vertex Pharmaceuticals
Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies.BDB
Universita Degli Studi Di Firenze
Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.BDB
University of Queensland
SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and Xa.BDB
Bristol-Myers Squibb
Structure-based optimization of novel azepane derivatives as PKB inhibitors.BDB
Roche Diagnostics
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors.BDB
Istituto Italiano Di Tecnologia